Nufarm (ASX:NUF) 17% EBITDA Jump, A$50m Cost Cut, and the De-leveraging Story Investors Missed

Net debt falls A$130m while a strategy reset quietly changes the earnings picture

Nufarm Limited’s (ASX:NUF) first-half update landed this morning and the headline number is straightforward. Underlying EBITDA for the six months to 31 March 2026 is tracking between A$239m and A$244m, which is roughly 17% above the prior corresponding period at the midpoint. That is a strong result. But what we think is being underappreciated is what is happening underneath it.

Net debt has fallen to approximately A$1.23 billion, down A$130m on the same time last year. Net debt to last-twelve-months EBITDA has improved to around 3.6x, a 20% reduction on the prior period. For a company that has carried elevated leverage concerns for some time, that trajectory matters.

The business also announced an additional A$50m gross cost savings program as part of its strategy refresh under incoming CEO Rico Christensen, who joined in January 2026. This is on top of A$50m in run-rate savings already achieved in FY25. The market has not fully connected those two data points yet, and we think that is where the investment opportunity sits.

Why the EBITDA Beat Is More Durable Than It Looks

The improvement in first-half profitability was not driven by a single one-off. Nufarm pointed to three distinct contributors. Crop Protection margins improved, Hybrid Seeds continued to grow, and the emerging omega-3 and bioenergy platforms contributed positively.

What that tells us is the earnings improvement has breadth. A margin recovery in Crop Protection tends to be cyclical, so investors should watch whether that holds in the second half. But the growth contribution from Hybrid Seeds and the emerging platforms suggests the business is building a more diversified earnings base, which reduces the risk profile over time.

Management also confirmed that the A$50m in prior-year savings are continuing to offset inflationary pressures in the current period. That means the margin structure is holding even as input costs and operational headwinds persist across the global crop protection industry.

What are the Best ASX Stocks to invest in right now?

Check our buy/sell tips

The New A$50m Cost Program Is the Real Catalyst

The additional A$50m gross cost savings program is the announcement investors should be spending the most time on, and we suspect many have glossed over it.

The savings relate to three areas. First, optimisation of manufacturing assets, including site footprint and product rationalisation. Second, manufacturing cost efficiencies. Third, reductions in selling, general and administrative costs. Cash implementation costs are expected to be approximately A$15m, weighted toward FY27, with the full savings run rate reached by the end of FY27.

What makes this interesting from a valuation standpoint is timing. The market typically reprices companies as those savings start flowing through, not when they are announced. That means the earnings impact is likely to show up progressively through FY27, which could make the current valuation look conservative if the programme executes cleanly.

De-leveraging Is the Story the Balance Sheet Is Now Telling

The reduction in net debt from A$1.36b to A$1.23b reflects disciplined working capital management and lower capital expenditure requirements. Nufarm has been explicit that reducing debt and leverage is a core pillar of the strategy refresh.

At 3.6x net debt to EBITDA, the company is still carrying above-average leverage by ASX agricultural standards. But the direction of travel is now clearly down. If the A$50m savings programme lands as targeted and EBITDA continues to improve modestly in FY27, the leverage ratio could compress toward 2.5x to 3.0x over the next 18 months, which would be a materially different risk profile.

The company has also flagged that positive trading momentum is continuing into April across all regions. Supply chains are broadly normalised and growers appear to be proceeding with normal seasonal activity despite higher fuel and fertiliser costs.

The Investors Takeaway for Nufarm

Nufarm is not a growth story in the traditional ASX sense. There is no pipeline of transformational catalysts or massive market expansion ahead of it. What it offers is a re-rating story, underpinned by earnings improvement, cost discipline, and balance sheet repair.

The next key catalyst is the formal 1H FY26 result release on 27 May 2026, which will include further detail on the strategy refresh and the cost programme. If management can demonstrate that the savings are on track and provide visibility into FY27 margin improvement, we think that is the point where the market begins to close the valuation gap.

The main risks are execution and macro. Crop protection markets remain subject to inventory cycles and pricing pressure. If the A$50m savings programme is delayed, or if Crop Protection margins soften in the second half, the earnings recovery could stall. The leverage ratio also remains elevated enough that any deterioration in cash flow would quickly reopen debt concerns.

On balance, the first-half update is a constructive data point. The business appears to be executing against a credible plan, and the combination of earnings improvement and balance sheet discipline gives Nufarm a clearer path to a better risk-reward profile than it has had in some time.